-
Integra LifeSciences Reports Fourth Quarter and Full-Year 2020 Financial Results
Post on 2/18/21
-
Johnson & Johnson's COVID-19 Vaccine Inventory Is Lighter Than Expected
Post on 2/18/21
-
Citius Pharmaceuticals Prices $76.5 Million Registered Direct Offering
Post on 2/17/21
-
Caladrius Biosciences Closes $65 Million Registered Direct Offerings
Post on 2/17/21
-
Cedar Partners With Summit CityMD to Offer a New, Patient-Forward Financial Experience
Post on 2/17/21
-
Onconova Therapeutics Closes $28.75M Public Offering of Common Stock
Post on 2/16/21
-
Zoetis Reports Fourth Quarter and Full Year 2020 Results
Post on 2/16/21
-
Outlook Therapeutics Reports Financial Results for First Quarter Fiscal Year 2021 and Provides Corporate Update
Post on 2/16/21
-
Teleflex Named One of America’s Best Employers 2021 by Forbes
Post on 2/16/21
-
Hepion Pharmaceuticals Prices of Public Offering
Post on 2/16/21
-
Here's Why You Can't Compare Vaccine Results Between Johnson & Johnson, Pfizer, and Moderna
Post on 2/16/21
-
What's the Outlook for Pfizer Stock?
Post on 2/16/21
-
Better Coronavirus Stock: Inovio Pharmaceuticals vs. Vaxart
Post on 2/16/21
-
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Post on 2/15/21
-
Caladrius Biosciences Announces $65 Million Registered Direct Offerings
Post on 2/12/21
-
3 Reasons Pfizer's Failures Could Lead to a Big Acquisition
Post on 2/12/21
-
Johnson & Johnson's Coronavirus Vaccine Data Isn't as Bad as It First Appears
Post on 2/12/21
-
VYNE Therapeutics Announces Reverse Stock Split
Post on 2/11/21
-
What Are Pfizer's Prospects in 2021 and Beyond?
Post on 2/11/21
-
Ortho Clinical Diagnostics: What You Need to Know
Post on 2/11/21
-
Onconova Therapeutics Prices of $25 Million Public Offering of Common Stock
Post on 2/11/21
-
Ocugen Closes $23M Registered Direct Offering of Common Stock
Post on 2/10/21
-
Onconova Therapeutics Proposes Public Offering of Common Stock
Post on 2/10/21
-
Healthcare Services Group Reports Q4 2020 Results
Post on 2/10/21
-
Catalent Launch of Private Offering of $475 Million of Senior Unsecured Notes
Post on 2/10/21
Philadelphia
